Total Payments
$53,697
2024 Payments
$1,249
Companies
14
Transactions
151
Payment Breakdown by Category
Education$25,246 (47.0%)
Other$18,534 (34.5%)
Consulting$8,101 (15.1%)
Research$962.50 (1.8%)
Food & Beverage$853.05 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $25,246 | 97 | 47.0% |
| Honoraria | $14,905 | 6 | 27.8% |
| Consulting Fee | $8,101 | 2 | 15.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,629 | 19 | 6.8% |
| Unspecified | $962.50 | 1 | 1.8% |
| Food and Beverage | $853.05 | 26 | 1.6% |
Payments by Type
General
$52,734
150 transactions
Research
$962.50
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | $27,274 | 80 | $0 (2024) |
| AveXis | $17,412 | 38 | $0 (2019) |
| Biogen, Inc. | $5,495 | 8 | $0 (2023) |
| Sarepta Therapeutics, Inc. | $2,833 | 2 | $0 (2021) |
| Genentech USA, Inc. | $191.75 | 3 | $0 (2024) |
| BioMarin Pharmaceutical Inc. | $151.89 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $110.90 | 2 | $0 (2024) |
| Genentech, Inc. | $82.22 | 2 | $0 (2021) |
| Greenwich Biosciences, Inc. | $57.67 | 3 | $0 (2020) |
| PTC Therapeutics, Inc. | $27.90 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,249 | 5 | Novartis Gene Therapies, Inc. (fka Avexis, Inc.) ($962.50) |
| 2023 | $2,606 | 12 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($2,531) |
| 2022 | $4,750 | 22 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($4,591) |
| 2021 | $10,468 | 22 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($7,618) |
| 2020 | $11,714 | 38 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($11,571) |
| 2019 | $17,559 | 49 | AveXis ($17,412) |
| 2018 | $5,350 | 3 | Biogen, Inc. ($5,350) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: RETT SYNDROME | ||||||
| 06/24/2024 | Genentech USA, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $146.67 | General |
| Category: Neurology | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | ZOLGENSMA (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Neurology | ||||||
| 04/12/2024 | Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | ZOLGENSMA (Drug) | — | Cash or cash equivalent | $962.50 | Research |
| Study: Research Medical Writing and Publication Support • Category: Neurology | ||||||
| 03/13/2024 | BioMarin Pharmaceutical Inc. | Palynziq (Drug) | Food and Beverage | In-kind items and services | $98.74 | General |
| Category: PKU | ||||||
| 10/04/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $75.00 | General |
| Category: GENE THERAPY | ||||||
| 08/23/2023 | Genentech USA, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Neurology | ||||||
| 06/29/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $914.29 | General |
| Category: GENE THERAPY | ||||||
| 06/29/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $75.00 | General |
| Category: GENE THERAPY | ||||||
| 06/20/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $75.00 | General |
| Category: GENE THERAPY | ||||||
| 05/24/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $75.00 | General |
| Category: GENE THERAPY | ||||||
| 04/26/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $166.67 | General |
| Category: GENE THERAPY | ||||||
| 04/18/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $41.67 | General |
| Category: GENE THERAPY | ||||||
| 03/19/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,066.67 | General |
| Category: GENE THERAPY | ||||||
| 03/01/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $41.67 | General |
| Category: GENE THERAPY | ||||||
| 02/07/2023 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Neurology | ||||||
| 01/17/2023 | BioMarin Pharmaceutical Inc. | Palynziq (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: PKU | ||||||
| 12/12/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $41.67 | General |
| Category: GENE THERAPY | ||||||
| 10/17/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $41.67 | General |
| Category: GENE THERAPY | ||||||
| 10/11/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $375.00 | General |
| Category: GENE THERAPY | ||||||
| 08/29/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $20.93 | General |
| 08/02/2022 | Novo Nordisk Inc | Norditropin (Biological) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Growth Hormone | ||||||
| 06/27/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: GENE THERAPY | ||||||
| 06/17/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $30.00 | General |
| Category: GENE THERAPY | ||||||
| 06/15/2022 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $90.44 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Research Medical Writing and Publication Support | Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | $962.50 | 1 |
About Dr. Kevin Strauss, MD
Dr. Kevin Strauss, MD is a Pediatrics healthcare provider based in Gordonville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1760602437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Strauss, MD has received a total of $53,697 in payments from pharmaceutical and medical device companies, with $1,249 received in 2024. These payments were reported across 151 transactions from 14 companies. The most common payment nature is "Education" ($25,246).
Ad
Practice Information
- Specialty Pediatrics
- Location Gordonville, PA
- Active Since 04/26/2007
- Last Updated 06/17/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1760602437
Products in Payments
- ZOLGENSMA (Biological) $40,224
- SPINRAZA (Biological) $5,495
- ZOLGENSMA (Drug) $982.96
- Evrysdi (Drug) $170.82
- Palynziq (Drug) $126.62
- Epidiolex (Drug) $57.67
- Exondys 51 (Drug) $33.13
- Non-Covered Product (Drug) $32.27
- Kuvan (Drug) $25.27
- Norditropin (Biological) $23.20
- DAYBUE (Drug) $20.48
- VALTOCO (Drug) $10.98
- (820) Cholbam (Drug) $4.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.